Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos
Launched by SAN DIEGO STATE UNIVERSITY · Nov 30, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
COVID-19 disparities are central to its local and national spread. Since the emergence of the novel coronavirus (SARS-CoV-2), there have been over 104.8 million confirmed cases worldwide, with the U.S. leading in number cases and deaths (as of this writing, \>26.6 mil and 455K+, respectively)1 and California leading the U.S. with \>3.3 mil cases.1 COVID-19 (the disease caused by SARS-CoV-2) is spread primarily from person-to-person through close and sustained contact with an infected individual. Unfortunately, the U.S. response to the pandemic has largely been left to state and local govern...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be a patient of an intervention participating clinic
- • Be an adult 18+
- • Self identify as Latino
- Exclusion Criteria:
- • Be planning to move out of San Diego County in the next 2 years
- • Have cognitive impairment making them unable to complete informed consent
- • Have any contraindications to receiving the 4 study vaccines (COVID-19, Pneumococcal, Shingles, Influenza)
About San Diego State University
San Diego State University (SDSU) is a leading academic institution recognized for its commitment to research and innovation in various fields, including health sciences. With a robust infrastructure for clinical trials, SDSU engages in cutting-edge research aimed at advancing medical knowledge and improving patient care. The university fosters collaboration among interdisciplinary teams of researchers, clinicians, and students, enabling the development of novel therapeutic interventions and evidence-based practices. SDSU's dedication to ethical standards and rigorous scientific methodologies ensures that its clinical trials contribute valuable insights to the medical community and enhance public health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
San Diego, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported